Jun 25, 2025, 08:26 AM by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

Jun 25, 2025, 08:26 AM by

Jun 25, 2025, 08:26 AM by

Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes

Jun 25, 2025, 08:26 AM by

To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.

Jun 25, 2025, 01:00 AM by User Not Found

Bio-IT World | ITM plans to use their financing to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide, which treats gastroenteropancreatic neuroendocrine tumors; GRIN and Angelini Pharma will develop and expand commercial rights outside of North America for GRIN's investigational drug radiprodil, which treats rare genetic epilepsies and neurodevelopmental disorders; and more.

Jun 24, 2025, 08:19 AM by

Vaxess Technologies, Inc., a biotech company developing a novel microarray patch technology to transform home delivery of therapies, is presenting new preclinical data at the 2025 American Diabetes Association (ADA) Scientific Sessions in Chicago.

Jun 24, 2025, 01:00 AM by User Not Found

Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

Jun 23, 2025, 08:09 AM by

Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.

Jun 23, 2025, 08:09 AM by

As supply chain instability and international backorders continue to affect the life sciences and diagnostics sectors, Zymo Research is stepping in with scalable, U.S.-based alternatives. Our latest announcement spotlights our domestic manufacturing capabilities and our role as a long-standing OEM and development partner, helping research and clinical labs maintain continuity without compromise. We believe this is especially relevant to your readers, many of whom are actively seeking reliable domestic partners. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/supply-chain-challenges

Jun 23, 2025, 08:09 AM by

Jun 23, 2025, 08:09 AM by

Bill Kerr of Avalon Healthcare Solutions Named EY Entrepreneur Of The Year® 2025 Florida Award Winner - Leader in Diagnostic Intelligence & Insights Earns Top Recognition for Transformative Work

Jun 23, 2025, 08:07 AM by

Lindus Health Named a Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category

Jun 23, 2025, 08:07 AM by

Jun 19, 2025, 01:00 AM by User Not Found

Bio-IT World | Nanoneedle technology developed by researchers from King’s College London offers the ability to extract molecular information from living tissue without damaging or killing cells—offering spatial and longitudinal molecular insights that is described as a “fundamental scientific breakthrough.”

Jun 18, 2025, 08:31 AM by

• Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples • Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs • Publication of pre-print data, with support from Evotec International GmbH and University College London demonstrates validation of Platform’s capability for liver diseases

Jun 18, 2025, 08:31 AM by

One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.

Jun 18, 2025, 08:31 AM by

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research. The study, presented at the American Thoracic Society, demonstrates significant clinical efficacy for Avalyn’s inhaled pirfenidone (AP01), a promising treatment for idiopathic pulmonary fibrosis (IPF), a rare and high-mortality lung disease.

Jun 18, 2025, 08:31 AM by

Jun 18, 2025, 08:31 AM by

MIB Agents, a leading pediatric osteosarcoma nonprofit, announced it has awarded $2.5 million in research grants through its OutSmarting Osteosarcoma program, which is powered by families honoring children affected by the disease. At its upcoming FACTOR Conference (June 26–28) in Salt Lake City, the organization will award $700,000 in grants to 10 scientists advancing less toxic, more effective treatments. The grants, which include four $100,000 Hero Grants and six $50,000 Hope Young Investigator Grants, reflect a unique collaboration between researchers and the osteosarcoma community, with families actively funding and participating in the review of scientific proposals.

Jun 18, 2025, 08:31 AM by